Sask. lab says its COVID-19 vaccine candidate has been found safe, issues open call for volunteers to receive it
The COVID-19 vaccine developed by the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan is safe, the lab announced Wednesday.
The most common reactions from the Phase 1 clinical trial for the vaccine, named COVAC-2, were a headache and mild injection site pain, which VIDO says are common after most immunizations.
In addition, even the lowest vaccine dose significantly increased the participants’ antibody levels, including neutralizing antibodies against SARS-CoV-2, VIDO says.
“The data continues to demonstrate the safety of our subunit vaccine COVAC-2,” Dr. Volker Gerdts, director and CEO of VIDO, said in a news release.
“We are encouraged by the vaccine’s ability to generate a significant immune response, even at the lowest dose tested.”
Subunit vaccines such as COVAC-2 contain purified viral proteins that are not infectious and the technology offers a history of safety and ease of storage and transport, VIDO says.
Participants continue to be recruited for the clinical trial in Halifax and a new clinical trial site will also open in Saskatoon later this summer.
Those 18 years and older who have not been infected with COVID-19 or received an authorized COVID-19 vaccine are eligible to volunteer.
They can contact the Clinical Trial Support Unit at ctsu@usask.ca or 306-978-8300.
CTVNews.ca Top Stories
Several flight attendants from Pakistan have gone missing after landing in Canada
Multiple flight attendants from Pakistan International Airlines have abandoned their jobs and are believed to have sought asylum in Canada in the past year and a half, a spokesperson for the government-owned airline says.
Premiers not being truthful about carbon tax, Trudeau says while sparks fly in Ottawa
Prime Minister Justin Trudeau says Conservative premiers across the country are 'not telling the truth' when it comes to the carbon tax. Trudeau's comments came as fresh sparks were flying in Ottawa at a recalled House of Commons committee.
A Nigerian woman reviewed some tomato puree online. Now she faces jail
A Nigerian woman who wrote an online review of a can of tomato puree is facing imprisonment after its manufacturer accused her of making a “malicious allegation” that damaged its business.
Far North police 'dispatch' polar bear stalking schoolyard
Police and local hunters in an Ontario Far North First Nation community have “dispatched” a polar that was showing abnormal behaviour and treating the area as a hunting ground.
Cargo ship had engine maintenance in port before Baltimore bridge collapse, officials say
The cargo ship that lost power and crashed into a bridge in Baltimore underwent 'routine engine maintenance' in port beforehand, the U.S. Coast Guard said Wednesday.
'Ninja,' Twitch's biggest streamer, is diagnosed with skin cancer
American gamer and Twitch superstar, Tyler 'Ninja' Blevins, revealed he was diagnosed with melanoma, a form of skin cancer.
Donald Trump assails judge and his daughter after gag order in N.Y. hush-money criminal case
Donald Trump lashed out Wednesday at the New York judge who put him under a gag order that bars him from commenting publicly about witnesses, prosecutors, court staff and jurors in his upcoming hush-money criminal trial.
Here's what Trudeau says the upcoming federal budget will offer renters
The federal government will create a new 'Canadian Renters' Bill of Rights,' which would require landlords to disclose their properties' rental price history to prospective tenants.
Families shocked after Niagara Falls hotel cancels bookings made year in advance of solar eclipse
After having the foresight to book their Niagara Falls hotel rooms more than a year in advance, several families planning to take in the solar eclipse next month were shocked to find out their reservations had been cancelled.